Real-Life Performance of F-18-FDG PET/CT in Patients with Cervical Lymph Node Metastasis of Unknown Primary Tumor
- PMID: 36140197
- PMCID: PMC9495705
- DOI: 10.3390/biomedicines10092095
Real-Life Performance of F-18-FDG PET/CT in Patients with Cervical Lymph Node Metastasis of Unknown Primary Tumor
Abstract
Background: Neoplasms in the head and neck region possess higher glycolytic activity than normal tissue, showing increased glucose metabolism. F-18-Flourodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) can identify an unknown primary tumor (CUP).
Aim: The aim of this study was to assess the real-life performance of F-18-FDG-PET/CT in detecting primary sites in patients with cervical lymph node metastasis of CUP.
Methods: A retrospective data analysis of 31 patients who received FDG-PET/CT between June 2009 and March 2015 in a CUP context with histologically confirmed cervical lymph node metastasis was included.
Results: In 48% of the patients (15/31), PET/CT showed suspicious tracer accumulation. In 52% of the patients (16/31), there was no suspicious radiotracer uptake, which was confirmed by the lack of identification of any primary tumor in 10 cases until the end of follow-up. FDG-PET/CT had a sensitivity of 67%, specificity of 91%, PPV of 92%, and NPV of 63% in detecting the primary tumor. Additionally, PET/CT showed suspicious tracer accumulation according to further metastasis in 32% of the patients (10/31).
Conclusion: FDG-PET/CT imaging is a useful technique for primary tumor detection in patients in a cervical CUP context. Furthermore, it provides information on the ulterior metastasis of the disease.
Keywords: CUP; FDG-PET/CT; lymph node metastasis; unknown primary tumor.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
Similar articles
-
Diagnostic performance of 18F-FDG PET/CT and whole-body diffusion-weighted imaging with background body suppression (DWIBS) in detection of lymph node and bone metastases from pediatric neuroblastoma.Ann Nucl Med. 2018 Jun;32(5):348-362. doi: 10.1007/s12149-018-1254-z. Epub 2018 Apr 17. Ann Nucl Med. 2018. PMID: 29667143 Free PMC article.
-
More advantages in detecting bone and soft tissue metastases from prostate cancer using 18F-PSMA PET/CT.Hell J Nucl Med. 2019 Jan-Apr;22(1):6-9. doi: 10.1967/s002449910952. Epub 2019 Mar 7. Hell J Nucl Med. 2019. PMID: 30843003
-
The impact of 18F-FDG PET/CT in the clinical management of patients with lymph node metastasis of unknown primary origin.Neoplasma. 2021 Jan;68(1):180-189. doi: 10.4149/neo_2020_200315N263. Epub 2020 Sep 3. Neoplasma. 2021. PMID: 32880466
-
Diagnostic accuracy of F-18 FDG PET or PET/CT for detection of lymph node metastasis in clinically node negative head and neck cancer patients; A systematic review and meta-analysis.Am J Otolaryngol. 2019 Mar-Apr;40(2):297-305. doi: 10.1016/j.amjoto.2018.10.013. Epub 2018 Oct 23. Am J Otolaryngol. 2019. PMID: 30473166
-
[18F]FDG-PET or PET/CT in the evaluation of pelvic and para-aortic lymph nodes in patients with locally advanced cervical cancer: A systematic review of the literature.Gynecol Oncol. 2020 Nov;159(2):588-596. doi: 10.1016/j.ygyno.2020.08.021. Epub 2020 Sep 10. Gynecol Oncol. 2020. PMID: 32921477
Cited by
-
18F-FDG PET/MRI and 18F-FDG PET/CT for the Management of Gynecological Malignancies: A Comprehensive Review of the Literature.J Imaging. 2023 Oct 13;9(10):223. doi: 10.3390/jimaging9100223. J Imaging. 2023. PMID: 37888330 Free PMC article. Review.
-
Imaging of cancer of unknown primary: a systematic literature review of the past, present, and future.Br J Radiol. 2025 Aug 1;98(1172):1209-1226. doi: 10.1093/bjr/tqaf039. Br J Radiol. 2025. PMID: 40117384 Free PMC article.
-
Advancements in Diagnostics and Therapeutics for Cancer of Unknown Primary in the Era of Precision Medicine.MedComm (2020). 2025 Apr 16;6(5):e70161. doi: 10.1002/mco2.70161. eCollection 2025 May. MedComm (2020). 2025. PMID: 40242159 Free PMC article. Review.
-
Utility of 18F-FDG PET/CT in Treatment Strategies for Patients With Cancer of Unknown Primary: A Single-Center, Retrospective Change-in-Management Study.Clin Med Insights Oncol. 2024 Apr 22;18:11795549241245691. doi: 10.1177/11795549241245691. eCollection 2024. Clin Med Insights Oncol. 2024. PMID: 38655397 Free PMC article.
References
-
- Fries F. Cervical CUP syndrome. Radiologe. 2020;60:1047–1051. - PubMed
-
- Mozet C., Wichmann G., Stumpp P. Cervical CUP syndrome. Onkologe. 2013;19:44–51.
-
- Golusinski P., Di Maio P., Pehlivan B. Evidence for the approach to the diagnostic evaluation of squamous cell carcinoma occult primary tumors of the head and neck. Oral Oncol. 2019;88:145–152. - PubMed
-
- Nassenstein K., Veit-Haibach P., Stergar H., Gutzeit A., Freudenberg L., Kuehl H., Fischer M., Barkhausen J., Bockisch A., Antoch G. Cervical lymph node metastases of unknown origin: Primary tumor detection with whole-body positron emission tomography/computed tomography. Acta. Radiol. 2007;48:1101–1108. doi: 10.1080/02841850701581768. - DOI - PubMed
LinkOut - more resources
Full Text Sources